Filmed live at the Hive, Atlanta, Georgia, on August 12, 2020. Dr. Baxter discusses her new nasal irrigation study beginning soon. She talks about active viral particles and viral load in the nose. Wear a mask! Viral load is correlated with severity of disease.
Study details: For COVID+ patients, ages 55+ Dr. Baxter’s nasal irrigation study begins soon! Does nasal irrigation (starting the day after a positive test) twice a day for 14 days decrease hospitalization, oxygen use, ICU placement, and mortality.
Earlier today, Dr. Baxter and our in-house physical therapist Dr. Keith Cronin DPT talked about using VibraCool Extended/Knee at home to reduce knee pain and increase strength & mobility.
Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.
Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.